1 / 35

Pre-TED 2400 Form Revision

Pre-TED 2400 Form Revision. Module 1. An educational module with audio Length: approx. 20 minutes. Objectives. Describe Form Revisions Review changes in Pre-TED submission Review Donor reporting Practice calculation to report preparative regimen drugs. Pre-TED Essentials.

kaden
Télécharger la présentation

Pre-TED 2400 Form Revision

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pre-TED 2400 Form Revision Module 1 An educational module with audio Length: approx. 20 minutes

  2. Objectives • Describe Form Revisions • Review changes in Pre-TED submission • Review Donor reporting • Practice calculation to report preparative regimen drugs

  3. Pre-TED Essentials NEW : The Pre-TED is now required for ALL HCTs.

  4. Submission Requirements

  5. Auto-population CRID Assignment Pre-TED Baseline

  6. New Section Order on Pre-TED • Key fields • Recipient Data • Hematopoietic Cellular Transplant (HCT) • Donor Information • Consent • Product Processing / Manipulation • Clinical Status of Recipient Prior to the Preparative Regimen • Co-morbid Conditions • Pre-HCT Preparative Regimen (Conditioning) • GVHD Prophylaxis • Other Toxicity Modifying Regimen • Post-HCT Disease Therapy Planned as of Day 0 • Primary Disease for HCT

  7. We removed HLA questions from the Pre-TED “HLA Reporting” (F2005)eLearning

  8. Recipient Data Ethnicity     • Hispanic or Latino • Not Hispanic or Latino • Not applicable (select - if not a resident of the USA) • Unknown Race • Not reported (if patient declined to provide) • Unknown

  9. Zip or Postal code 5 Digits – The Recipient’s Home Address.

  10. Clinical Trials Question 6: Is the recipient participating in a clinical trial? • RCI-BMT (Resource for Clinical Investigation in Blood and Marrow Transplantation) • BMT-CTN (Blood and Marrow Transplant Clinical Trials Network) • USIDNET (United States Immunodeficiency Network) • COG (Children’s Oncology Group) • Other sponsor Human stem cells

  11. Hematopoietic Cellular Transplant (HCT) Form Section

  12. Donor Information Expanded

  13. ISBT DIN Number • Example of an ISBT DIN Number: • G1517 09 123456 • Facility ID number – 5 characters • Collection Year – 2 digits • Serial Number – 6 digits http://www.iccbba.org/

  14. CIBMTR Registry Codes • Added New Options: • St Louis Cord Blood Bank – SLCBB • Viacord /Sibling Connection – VIAC • Other • Revised: • Caitlyn Raymond (CRIR) (previously USA3 and U3CB) . . .should now be reported under NMDP Codes (USA1 and U1CB)

  15. Choosing the right Registry Code

  16. CBU shipment

  17. Additional Donor Questions Added

  18. IRB-approved Consent New option – Not applicable, means ‘patient not approached’

  19. New Consent Questions Question 69: Has the donor signed an IRB-approved consent form for submitting research blood samples to the NMDP/CIBMTR? (Related donors only) • Question 65: Did the recipient give permission to be directly contacted for future research?

  20. Research Sample Repository Center Participation

  21. Diluted • Buffy coat enriched • B-cell reduced • CD8 reduced • Plasma reduced • RBC reduced • Cultured • Genetic Manipulation • PUVA treated • CD34 enriched (CD34+selection) • CD133 enriched • Monocyte enriched • Mononuclear cells enriched

  22. CoMorbid Conditions • “Were there clinically significant co-existing diseases or organ impairment at time of patient assessment prior to preparative regimen?” Resource: Data Management Manual Appendix U

  23. Pre-HCT Preparative Regimen (Conditioning)

  24. Preparative Regimen Intensity (Question158)

  25. Radiation Therapy Enter prescribed dose per fraction in either gray (Gy) or centigray (cGy). Dose per fraction x total number of fractions from Question: 167, must be equal to the total dose reported in Question: 162

  26. Radiation Reporting – Question 166 Number of days prescribed includes days of REST between days of therapy.

  27. Do Not Include These Drugs • Corticosteroids for nausea • MESNA for hemorrhagic cystitis • Therapy drugs given between 1st and subsequent HCTs • After Day 0 - ATG and Campath (report in GVHD section - questions 316-341) They are NOT preparative regimen

  28. Total Prescribed Cumulative Dose Questions 168 - 315

  29. Patient Scenario • A 10 year old child with AML is admitted for BuCy conditioning. The patient weighs 35 kg. • The preparative regimen per transplant protocol includes: • Bu 0.8 mg/kg/dose IV every 6 hours x 16 doses (q6h x 4 a day x 4 days = 16 doses) 0.8 mg/kg x16 = 12.8 mg/kg 12.8 rounded to 13 Bu dose to report: 13 mg/kg

  30. Patient Scenario (continued) • A 10 year old child with AML is admitted for BuCy conditioning. The patient weighs 35 kg. The preparative regimen per transplant protocol includes: • Cy 60 mg/kg/day IV daily x 2 doses 60 X 2 = 120 mg/kg dose x # of doses Cy dose to report: 120 mg/kg

  31. 2400 Knowledge Check

  32. End of Module 1 CIBMTRTraining@nmdp.org

More Related